Volume 5.34 | Sep 1

ESC & iPSC News 5.34, September 1, 2010.
In this issue:  Science News |  Current Publications |  Industry News |  Policy News |  Events
Subscribe  |  Unsubscribe

 


TOP STORY

Hepatoblast-Like Progenitor Cells Derived from Embryonic Stem Cells Can Repopulate Livers of Mice 
Embryonic stem cell-derived c-Kit(-)EpCAM(+) cells contain a population of hepatoblast-like progenitor cells that can repopulate livers of mice. [Gastroenterology]

mFreSR_645x110_v01

SCIENCE NEWS

Applying Stem Cell Technology to Liver Diseases
Induced pluripotent stem cells (iPS cells) hold promise for cell replacement therapy and modeling human disease. Two independent research groups — at the University of Cambridge, United Kingdom, and the University of California San Francisco — have now shown that both possibilities are true for iPS cell-derived liver cells. [Press release from EurekAlert! discussing online prepublication in the Journal of Clinical Investigation]

STEMcircles_645x110

CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal)

Modeling Inherited Metabolic Disorders of the Liver Using Human Induced Pluripotent Stem Cells
Researchers report a simple and effective platform for hepatocyte generation from patient-specific human induced pluripotent stem cells. [J Clin Invest]

Induced Pluripotent Stem Cell-Derived Hepatocytes Have the Functional and Proliferative Capabilities Needed for Liver Regeneration in Mice
In vivo analyses showed that induced pluripotent stem cells were intrinsically able to differentiate into fully mature hepatocytes that provided full liver function. [J Clin Invest]

Differential Regulation of Proliferation and Differentiation in Neural Precursor Cells by the Jak Pathway
Results suggest that neuronal precursor cell proliferation and differentiation are differentially regulated by the Jak pathway. [Stem Cells]
 
Gli1 is an Inducing Factor in Generating Floor Plate Progenitor Cells From Human Embryonic Stem Cells
Researchers show that forced expression of the transcription factor GLI1 in human embryonic stem cells at the earliest stage of neural induction, resulted in their commitment to floor plate lineage. [Stem Cells]

A Role for Regulatory T Cells in Acceptance of Embryonic Stem Cell-Derived Tissues Transplanted Across an MHC Barrier
Spontaneous acceptance of embryonic stem cell-derived tissues mimics the acquired immune privilege induced by co-receptor blockade and is determined by regulatory T cell-mediated suppression. [Stem Cells]

MicroRNA-1 Regulates Smooth Muscle Cell Differentiation by Repressing KLF4
Researchers sought to uncover novel targets of and shed light on the function of miR-1 in the context of embryonic stem cell differentiation of smooth muscle cells in vitro. [Stem Cells Dev]

Fetal Stromal Niches Enhance Human Embryonic Stem Cell-Derived Hematopoietic Differentiation and Globin Switch
Researchers investigated the effects of primary stromal cells from fetal hematopoietic niches and their conditioned media, applied singly or in sequential orders, on induction of human embryonic stem cells, H1, H9 and H14 lines, to hematopoietic stem/progenitor cells. [Stem Cells Dev]

Modulated Differentiation of Embryonic Stem Cells into Hepatocyte-Like Cells by Coculture with Hepatic Stellate Cells
Hepatic stellate cells have contrasting effects on embryoid bodies undergoing differentiation and undifferentiated embryonic stem cells, i.e., positive and negative modulation, respectively. [J Biosci Bioeng]

INDUSTRY NEWS

Roche and Aileron Enter Multi-Target Alliance to Develop Stapled Peptide Drugs for Diseases Across Multiple Therapeutic Areas
Aileron Therapeutics and Roche announced that they have entered into a collaboration to discover, develop and commercialize a new class of drugs called Stapled Peptide Therapeutics. [Aileron Therapeutics Press Release]

Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme
Sanofi-aventis announced that it has submitted a non-binding proposal to acquire Genzyme in an all-cash transaction valued at approximately $18.5 billion. [Sanofi-aventis Press Release]

Genzyme Confirms Receipt of Unsolicited Proposal
Genzyme Corp. confirmed that it has received an unsolicited, non-binding proposal from Sanofi-aventis to acquire all the outstanding shares of Genzyme for $69 per share in cash. The Genzyme board of directors unanimously affirmed its previous rejection of Sanofi’s proposal. [Genzyme Press Release]

POLICY NEWS

Obama Administration Appeals Stem Cell Injunction
The Obama administration appealed a ruling that blocked federal funding of embryonic stem cell research and asked the judge who issued the injunction to put it on hold pending the appeal. [Administration, United States]

NIH Orders Immediate Shutdown of Intramural Human Embryonic Stem Cell Research
Responding to a court order, the National Institutes of Health (NIH) ordered intramural researchers studying human embryonic stem cells to shut down their experiments. [National Institutes of Health, United States]

NIH Asks Judge to Suspend Stem Cell Research Injunction
Warning of a “devastating impact” on ongoing research, the National Institutes of Health (NIH) asked a federal court to stay a preliminary injunction that last week forced NIH to suspend future grant payments to study human embryonic stem cells (hESC) and shut down its in-house research on hESCs. [National Institutes of Health, United States]

NIH Director’s Response to Stem Cell Injunction [National Institutes of Health, United States]

Status of Applications and Awards Involving Human Embryonic Stem Cells, and Submissions of Stem Cell Lines for Eligibility Consideration (NOT-OD-10-126) [National Institutes of Health, United States]

Request for Comments on Synthetic Biology (FR Doc. 2010-21359) [Department of Health and Human Services, United States]
 
Notice of Meeting: Secretary’s Advisory Committee on Genetics, Health, and Society (FR Doc. 2010-21532) [Department of Health and Human Services, United States]

Office of the Director, National Institutes of Health; Notice of Meeting (FR Doc. 2010-20861) [National Institutes of Health, United States]
 
Center for Scientific Review; Notice of Closed Meetings (FR Doc. 2010-21357) [National Institutes of Health, United States]
 
National Cancer Institute; Notice of Closed Meeting (FR Doc. 2010-21282) [National Institutes of Health, United States]
 
National Center for Research Resources; Notice of Closed Meeting (FR Doc. 2010-21280) [National Institutes of Health, United States]
 
Public Workshop on Cell and Gene Therapy Clinical Trials in Pediatric Populations [Center for Biologics Evaluation and Research, Untied States]
 
Guidance for Industry: Electronic Submission of Lot Distribution Reports for Biological Products [Center for Biologics Evaluation and Research, Untied States]

Food and Drug Administration Clinical Trial Requirements, Regulations, Compliance, and Good Clinical Practice; Public Workshop [FR Doc. 2010-20834] [Food and Drug Administration, United States]

EVENTS

International Society for Cellular Therapy (ISCT) – Europe 2nd Regional Meeting
September 11-14, 2010
Belgirate, Italy

Hydra VI: The European Summer School on Stem Cells & Regenerative Medicine
September 11-17, 2010
Hydra, Greece

Stem Cells USA & Regenerative Medicine Congress 2010
September 13-15, 2010
Philadelphia, United States


Tissue Engineering & Regenerative Medicine International Society (TERMIS) – Asia Pacific 2010
September 15-17, 2010
Sydney, Australia

5th Annual Meeting of the German Society for Stem Cell Research
September 30-October 2, 2010
Lübeck, Germany

5th World Congress on Preventive & Regenerative Medicine (WCRM) 2010
October 5-7, 2010
Hannover, Germany

Induced Pluripotent Stem Cells: Production and Utility in Regenerative Medicine
October 7, 2010
Hertfordshire, United Kingdom

Fraunhofer Life Science Symposium Leipzig 2010
October 29-30, 2010
Leipzig, Germany

BioMalaysia 2010 Conference and Exhibition
November 2-4, 2010
Kuala Lumpur, Malaysia

Select Biosciences 2nd International Forum on Stem Cells
November 12-13, 2010
Tianjin, China


Stem Cell Network 10th Annual Scientific Meeting
November 22-24, 2010
Calgary, Canada

Tissue Engineering & Regenerative Medicine International Society (TERMIS) – North America 2010 Annual Conference
December 5-8, 2010
Orlando, United States

Biotech Showcase 2011
January 10-12, 2011
San Francisco, United States 

Stem Cells World Congress
January 24-25, 2011
San Diego, United States


Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.


 

JOB OPPORTUNITIES

Cell Therapy Technologist (Opexa Therapeutics)

Recruit Top Talent

Reach more than 11,000 potential candidates by posting your organization’s career opportunities with ESC & iPSC News.

Visit here to post your career opportunities.


 

 

 

 Learn more about ESC & iPSC News:  Archives |  Events |  Subscribe |  Contact Us